• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚苯乙烯磺酸鈉预处理婴儿配方奶粉:关注最佳用量和接触时间。

Pretreatment of infant formula with sodium polystyrene sulfonate : focus on optimal amount and contact time.

机构信息

School of Pharmacy, University of Waterloo, Waterloo, ON, Canada.

出版信息

Paediatr Drugs. 2013 Feb;15(1):43-8. doi: 10.1007/s40272-012-0003-3.

DOI:10.1007/s40272-012-0003-3
PMID:23329388
Abstract

BACKGROUND

In pediatric patients at risk of hyperkalemia there are limited treatment or preventive alternatives for this electrolyte imbalance. Oral or rectal sodium polystyrene sulfonate (SPS) has several potential adverse effects, and dietary potassium restriction may compromise nutrition. Pretreatment of infant formula with SPS has been previously studied with promising efficacy. The optimal dosing and contact time has not been fully elucidated for this practice, nor have brand and generic products been compared.

OBJECTIVE

The present study aimed to evaluate the effectiveness of varying amounts of brand and generic SPS for the removal of potassium from formula after 1 and 24 hours.

METHODS

SPS was added to infant formula in four different amounts measured in milliliters to reflect how a parent or caregiver would measure this product at home. After 1 and 24 hours samples were withdrawn and potassium and sodium levels were measured.

RESULTS

Potassium decreased in all samples, with the greatest reduction after the addition of 10 mL of SPS. Sodium levels increased in all pretreated samples to a greater extent than the potassium reduction. Contact time of either 1 or 24 hours did not impact the amount of potassium removed or the increase in sodium concentration. There were also no differences found between generic and brand SPS products.

CONCLUSION

The effectiveness of SPS for formula pretreatment appears to have a plateau effect beyond the addition of 20 mL (16.47 g of brand name product, 19.5 g of generic product). This study demonstrates an effective protocol for pretreatment of formula.

摘要

背景

在有发生高钾血症风险的儿科患者中,针对这种电解质失衡的治疗或预防方法有限。口服或直肠给予聚苯乙烯磺酸钙(SPS)有多种潜在的不良反应,而限制钾的摄入可能会影响营养。先前已有研究使用 SPS 对婴儿配方奶粉进行预处理,且效果良好。但这种方法的最佳剂量和接触时间尚未完全阐明,也尚未比较过品牌和仿制药产品。

目的

本研究旨在评估不同剂量和品牌的 SPS 对配方奶粉中钾的去除效果,分别在 1 小时和 24 小时后进行评估。

方法

以毫升为单位,向婴儿配方奶粉中添加 SPS,添加量分为 4 个不同水平,以反映父母或护理人员在家中测量该产品的方式。在 1 小时和 24 小时后抽取样本,测量钾和钠的水平。

结果

所有样本中的钾含量均降低,添加 10 毫升 SPS 后降低幅度最大。所有预处理样本中的钠含量均升高,且升高幅度大于钾的减少幅度。接触时间为 1 小时或 24 小时均未影响钾的去除量或钠浓度的增加。此外,仿制药和品牌药 SPS 产品之间也未发现差异。

结论

SPS 对配方奶粉预处理的效果似乎存在一个平台效应,超过添加 20 毫升(16.47 克品牌产品,19.5 克仿制药产品)后效果不再增加。本研究为配方奶粉的预处理提供了一个有效的方案。

相似文献

1
Pretreatment of infant formula with sodium polystyrene sulfonate : focus on optimal amount and contact time.聚苯乙烯磺酸鈉预处理婴儿配方奶粉:关注最佳用量和接触时间。
Paediatr Drugs. 2013 Feb;15(1):43-8. doi: 10.1007/s40272-012-0003-3.
2
Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate(®)) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency.用聚苯乙烯磺酸鈉(Kayexalate(®))预处理配方奶或挤出的母乳,以治疗急性或慢性肾功能不全的婴儿高钾血症。
J Ren Nutr. 2013 Sep;23(5):333-9. doi: 10.1053/j.jrn.2013.02.011. Epub 2013 May 23.
3
[Case report of an infant hyperkalemia: Suggestion of a hospital procedure for the milk pretreatment with sodium polystyrene sulfonate resin].[一例婴儿高钾血症病例报告:关于使用聚苯乙烯磺酸钠树脂对牛奶进行预处理的医院操作建议]
Ann Pharm Fr. 2020 Jul;78(4):287-293. doi: 10.1016/j.pharma.2020.02.005. Epub 2020 Apr 3.
4
Evaluation of Sodium Polystyrene Sulfonate Dosing Strategies in the Inpatient Management of Hyperkalemia.聚苯乙烯磺酸钠给药策略在高钾血症住院治疗中的评估
Ann Pharmacother. 2016 Jun;50(6):455-62. doi: 10.1177/1060028016641427. Epub 2016 Apr 5.
5
Polysulfonate Resins in Hyperkalemia: A Systematic Review.聚磺酸盐树脂治疗高钾血症的系统评价
Can J Kidney Health Dis. 2020 Oct 30;7:2054358120965838. doi: 10.1177/2054358120965838. eCollection 2020.
6
Mineral content of infant formula after treatment with sodium polystyrene sulfonate or calcium polystyrene sulfonate.
Adv Perit Dial. 1998;14:274-7.
7
Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate.用聚苯乙烯磺酸钠治疗小儿高钾血症。
Pediatr Nephrol. 2016 Nov;31(11):2113-7. doi: 10.1007/s00467-016-3414-5. Epub 2016 May 23.
8
Renal formulas pretreated with medications alters the nutrient profile.用药物预处理的肾脏配方会改变营养成分。
Pediatr Nephrol. 2015 Oct;30(10):1815-23. doi: 10.1007/s00467-015-3115-5. Epub 2015 May 1.
9
Pretreatment of formula with sodium polystyrene sulfonate to reduce dietary potassium intake.用聚苯乙烯磺酸钠对配方进行预处理以减少膳食钾摄入量。
Pediatr Nephrol. 1991 Jan;5(1):29-32. doi: 10.1007/BF00852836.
10
Sodium polystyrene sulfonate used to reduce the potassium content of a high-protein enteral formula: a quantitative analysis.
JPEN J Parenter Enteral Nutr. 2004 Mar-Apr;28(2):76-8. doi: 10.1177/014860710402800276.

引用本文的文献

1
Case report: Early molecular confirmation and sodium polystyrene sulfonate management of systemic pseudohypoaldosteronism type I.病例报告:I 型全身性假性醛固酮减少症的早期分子确认和聚苯乙烯磺酸钠管理。
Front Endocrinol (Lausanne). 2024 Jan 15;14:1297335. doi: 10.3389/fendo.2023.1297335. eCollection 2023.
2
Nutritional management of the infant with chronic kidney disease stages 2-5 and on dialysis.慢性肾脏病 2-5 期和透析婴儿的营养管理。
Pediatr Nephrol. 2023 Jan;38(1):87-103. doi: 10.1007/s00467-022-05529-x. Epub 2022 Apr 5.
3
The dietary management of potassium in children with CKD stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce.

本文引用的文献

1
Nutritional management of hyperkalemic infants with chronic kidney disease, using adult renal formulas.用成人肾脏配方治疗慢性肾脏病高钾血症婴儿的营养管理。
J Ren Nutr. 2010 Mar;20(2):121-6. doi: 10.1053/j.jrn.2009.06.003. Epub 2009 Oct 22.
2
Sodium polystyrene sulfonate (Kayexalate) aspiration.聚苯乙烯磺酸钠(Kayexalate)吸入。
Diagn Pathol. 2008 Jun 17;3:27. doi: 10.1186/1746-1596-3-27.
3
Rectal stenosis caused by foreign body reaction to sodium polystyrene sulfonate crystals (Kayexalate).聚苯乙烯磺酸钠晶体(降钾树脂)异物反应所致直肠狭窄。
KDIGO 临床实践指南:儿童慢性肾脏病 2-5 期及透析患者的钾饮食管理—儿科肾脏营养工作组的实践推荐
Pediatr Nephrol. 2021 Jun;36(6):1331-1346. doi: 10.1007/s00467-021-04923-1. Epub 2021 Mar 17.
4
The ice cream challenge: A favourable extemporaneous Kayexalate formulation improves compliance in paediatric patients.冰淇淋挑战:一种适宜的即配聚苯乙烯磺酸钠制剂可提高儿科患者的依从性。
Br J Clin Pharmacol. 2019 Oct;85(10):2450-2452. doi: 10.1111/bcp.14067. Epub 2019 Aug 7.
5
Let food be thy medicine and medicine be thy food?让食物成为你的药物,让药物成为你的食物?
Clin Kidney J. 2018 Apr;11(2):162-165. doi: 10.1093/ckj/sfy008. Epub 2018 Feb 26.
6
Pretreatment of enteral nutrition with sodium polystyrene sulfonate: effective, but beware the high prevalence of electrolyte derangements in clinical practice.聚苯乙烯磺酸钠进行肠内营养预处理:有效,但临床实践中要警惕电解质紊乱的高发生率。
Clin Kidney J. 2018 Apr;11(2):166-171. doi: 10.1093/ckj/sfx138. Epub 2017 Dec 21.
7
Renal formulas pretreated with medications alters the nutrient profile.用药物预处理的肾脏配方会改变营养成分。
Pediatr Nephrol. 2015 Oct;30(10):1815-23. doi: 10.1007/s00467-015-3115-5. Epub 2015 May 1.
Ann Diagn Pathol. 2007 Jun;11(3):217-9. doi: 10.1016/j.anndiagpath.2006.02.001.
4
Sodium polystyrene sulfonate used to reduce the potassium content of a high-protein enteral formula: a quantitative analysis.
JPEN J Parenter Enteral Nutr. 2004 Mar-Apr;28(2):76-8. doi: 10.1177/014860710402800276.
5
Acute colonic necrosis associated with sodium polystyrene sulfonate (Kayexalate) enemas in a critically ill patient: case report and review of the literature.
J Trauma. 2001 Aug;51(2):395-7. doi: 10.1097/00005373-200108000-00031.
6
Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol: clinical, endoscopic, and histopathologic findings.接受山梨醇聚苯乙烯磺酸钠(降钾树脂)治疗的患者上消化道损伤:临床、内镜及组织病理学 findings。 (原文“findings”此处直接保留英文,因为其确切含义需结合上下文确定,暂无法准确翻译)
Am J Surg Pathol. 2001 May;25(5):637-44. doi: 10.1097/00000478-200105000-00011.
7
Mineral content of infant formula after treatment with sodium polystyrene sulfonate or calcium polystyrene sulfonate.
Adv Perit Dial. 1998;14:274-7.
8
[Effect of ion exchange resins on the composition of milk].[离子交换树脂对牛奶成分的影响]
Nephrologie. 1997;18(7):287-9.
9
Reduction of potassium in drinks by pre-treatment with calcium polystyrene sulphonate.
Eur J Pediatr. 1993 Mar;152(3):263-4. doi: 10.1007/BF01956159.
10
Pretreatment of formula with sodium polystyrene sulfonate to reduce dietary potassium intake.用聚苯乙烯磺酸钠对配方进行预处理以减少膳食钾摄入量。
Pediatr Nephrol. 1991 Jan;5(1):29-32. doi: 10.1007/BF00852836.